Stay updated on TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Expanded indexing with a large set of study keywords and entity names (drugs, diseases, investigators, and institutions). Removed an error page block to restore access to content.
    Difference
    56%
    Check dated 2026-08-17T13:58:26.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Footer revision label updated from Revision: v3.6.4 to Revision: v3.6.5, indicating a newer page version. This is a minor maintenance update that does not alter study content or functionality.
    Difference
    0.1%
    Check dated 2026-08-10T10:44:47.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    A new Revision: v3.6.4 tag was added, replacing Revision: v3.6.3, indicating a small platform update rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-27T05:35:01.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Footer revision updated from v3.6.2 to v3.6.3, signaling a new site version deployment. This update does not alter study information or page content.
    Difference
    0.1%
    Check dated 2026-07-05T14:38:25.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page's site revision was updated from v3.6.0 to v3.6.2, indicating a minor platform update. The change appears in the footer as a version tag and does not alter the study information shown.
    Difference
    0.1%
    Check dated 2026-06-28T08:17:29.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page adds separate entries for the investigator and sponsoring institution (HW Kapiteijn and Leiden University Medical Center) and introduces new navigation links such as How to Read a Study Record, Common Questions, and How to Join a Study. It also updates the status/verification labels and changes the label formatting for Intervention/Treatment, plus updates the revision/version from v3.5.5 to v3.6.0.
    Difference
    1%
    Check dated 2026-06-14T05:44:48.000Z thumbnail image

Stay in the know with updates to TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page.